Tumor cell vasculogenic mimicry: from controversy to therapeutic promise - Wikidata - awgldk - TriplyDB

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise

http://www.wikidata.org/entity/Q26829921

about

Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization Brain tumor-targeted drug delivery strategies Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1.Vascular channels formed by subpopulations of PECAM1+ melanoma cells.Macrophages form functional vascular mimicry channels in vivo Cancer stem cells: a systems biology view of their role in prognosis and therapy Revisiting the hallmarks of cancer.Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer Vasculogenic mimicry of HT1080 tumour cells in vivo: critical role of HIF-1α-neuropilin-1 axis.OCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancer.Angiotropism, pericytic mimicry and extravascular migratory metastasis in melanoma: an alternative to intravascular cancer dissemination.Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia.Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells.Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.Incarvine C suppresses proliferation and vasculogenic mimicry of hepatocellular carcinoma cells via targeting ROCK inhibition.Matrix metalloproteinases as breast cancer drivers and therapeutic targets.Vasculogenic mimicry is a major feature and novel predictor of poor prognosis in patients with orbital rhabdomyosarcoma.Spatial organization of the tenascin-C microenvironment in experimental and human cancer CD44 enhances tumor aggressiveness by promoting tumor cell plasticity.Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response Expression of high mobility group box 1 protein predicts a poorer prognosis for patients with osteosarcoma.Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts A bladder cancer microenvironment simulation system based on a microfluidic co-culture model Pilot study on "pericytic mimicry" and potential embryonic/stem cell properties of angiotropic melanoma cells interacting with the abluminal vascular surface.Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor.Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K.Targeting tumor vasculature through oncolytic virotherapy: recent advances.Vasculogenic mimicry in small cell lung cancer.Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib.Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis.M2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expression in glioma cells.The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor.Vasculogenic mimicry in hepatocellular carcinoma contributes to portal vein invasion.CD133-targeted niche-dependent therapy in cancer: a multipronged approach.

P2860

Q26781833-6D37E542-57B4-4704-80A4-4538D0F40FA3 Q26829741-7A6A0F5F-EA6E-4341-B0F7-A13E76A10C2A Q28067753-8ED7CAE5-9A9E-4375-A009-6C4491AFAFCB Q28077123-C7AC8900-695D-4BFF-9872-BDB0CC814D49 Q30009429-858563C5-A633-4B94-A35C-EFE172EDC1E7 Q30413784-390FC861-EDF5-4658-8BFE-19D443DEFAD7 Q30828304-6C3F55E9-4D4E-4AB5-B28C-B21A9B06E342 Q33569712-0935916A-03CA-4355-A84F-2A32A61CDB93 Q33732986-2EE50AE6-169D-4899-9EBD-66FB312B6F42 Q33761711-4D681A76-244E-4A30-9FA1-A64C136827F0 Q33779474-7474E805-9833-4F46-A6AF-9B0E210E1AB0 Q34207659-51E0AEED-7C78-4958-B95A-BE3B4F0AD42F Q34491119-975F3BEE-63E4-4C85-BE0C-C7768E9E91E0 Q34685016-1BB456DB-9004-4A3A-B7B5-92C327F9C0AE Q34766649-8870CEFC-CE4E-4A42-8D29-3EF05BA24678 Q34786452-702FD5BE-0CB5-4195-88E9-2F1A5A3CF319 Q35099880-75A17D83-5904-4D72-BA84-F4E3B5D57D44 Q35179190-A67F10E5-54BB-4D88-8E2A-407F0C4E9210 Q35463820-1D1E31B4-02D3-43B3-9BDA-8FDE908093FD Q35741127-67989C18-5171-4797-AD93-BD715B90EA47 Q35824952-94D96BB1-6F91-4CBC-A1A6-57B554FBB3DA Q35892721-308A9CC5-BFA5-48D6-886B-8F116EA073B6 Q35943307-9F33182D-B7E5-46DD-8908-6E643001B3E8 Q36125171-D53844C8-95ED-48CA-B951-92EAFA6B448B Q36260608-2AF551A2-91A1-4EDA-9197-1C1B13DC54D6 Q36355916-607F8EFE-9A68-4FE7-9254-0D54361C5827 Q36502721-CE26B02C-A10C-4D55-A3F1-CB3772745E71 Q36545764-3E37EB87-EF4D-41A1-A5E2-4CE6D7A58250 Q36545853-8D7BDEDF-EA80-4613-B835-FBE3EFBE9802 Q36695074-BA87EF45-3248-4A17-8881-201FA7134B3A Q36742307-061FBA0E-D067-4147-BCF2-2683E35D6F9F Q37015731-0B44A8D0-33D6-4219-B9C1-009CFC078165 Q37031932-6EBB40B0-F1F6-43D0-BD9C-41E759BCA4C2 Q37408684-743DE5D9-3E76-4F07-8A5B-B86A4B96EBB0 Q37437544-F11FD616-DEED-4FDD-A6A6-D0EE34FB485D Q37480166-193ECE2A-7029-4047-8C54-85EA499B8FA6 Q37702362-8316CCEE-2720-42AA-8C43-F6F6C5590A03 Q37705532-80C13A08-2F79-4448-A857-61A4AFEEB875 Q37718478-7FF95CD7-55EC-4587-A182-F2A4FB8E2726 Q37734881-3147E32B-D0D0-40AA-9C67-F41ACAFA757F

P2860

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise

http://www.wikidata.org/entity/Q26829921

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise

@ast

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise

@en

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise

@nl

type

label

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise

@ast

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise

@en

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise

@nl

prefLabel

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise

@ast

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise

@en

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise

@nl

P1433

Q26829921-C6591B65-115B-4EDA-A75B-B68B5DBA5A97

P1476

Q26829921-37E0995C-6F8C-4C61-8787-8720DA1ADFB6

P2093

Q26829921-368C7962-9AE2-4150-9AB3-AB5734752362

Q26829921-6EAD4F54-AA65-4ED6-9AA9-431CEA086951

Q26829921-791DB3D2-BC98-48C6-A358-6EA83CC00C93

Q26829921-93490920-870F-495C-AD3F-ED71C0A7E4CB

Q26829921-97B266E3-10C7-486E-8A22-E48606431D8F

Q26829921-A3B1E7BC-291A-47CE-BBFA-B4C29ED7101D

Q26829921-EEA7A224-2B91-4219-B5A0-75937E35FFF8

P2860

Q26829921-03FD960C-0C25-4CF2-8BFA-3660CC339E35

Q26829921-054F3FB6-8B25-4996-BDAF-47DEF9B37898

Q26829921-135A5CA2-F973-4340-AB98-A484BD2D0E6E

Q26829921-15A1A4C3-D0EE-4C51-AF50-1062C35D7E23

Q26829921-2530DC3C-41ED-471F-977F-FB48C5186212

Q26829921-29FAD647-DE5F-4332-B1E0-262901719B6D

Q26829921-2EECD6F1-5DBE-4FDE-872C-6EBF538ABB0F

Q26829921-33556E91-B902-4FD2-8546-D5CED0003C84

Q26829921-3C1C0839-5886-4631-B4A8-6C7955E3EF39

Q26829921-3E5B6248-6B5A-49B5-B2CF-D065D3192D67

P304

Q26829921-94D43D1C-F2AF-4A47-A9F0-10399EA1CC8E

P31

Q26829921-77B5F940-2DF4-47C8-998C-E2E57D2559C0

P3181

Q26829921-84C021ED-B680-4811-8976-92FAC841FB5C

P356

Q26829921-4E9DD82A-682C-4F67-BDDC-9714AFBE7995

P407

Q26829921-386DE729-A30F-4B34-90CD-02EE06740BEA

P433

Q26829921-7651275E-6CC8-4781-AF4B-31CC4C105A2C

P478

Q26829921-9356ED38-2BBA-4DC8-9A5C-B36A9824B34F

P577

Q26829921-952CF683-C60D-4344-981C-8CE76FF3DB3E

P5875

Q26829921-9CB639CC-1D35-4B10-9EC7-28A8E7320D5E

P698

Q26829921-79B7D720-38A6-4206-84D9-3CF3431F93D3

P932

Q26829921-046F3767-842E-40C6-96C6-DB15E2CAB237

P3181

P356

J.AJPATH.2012.07.013

P1433

The American Journal of Pathology

P1476

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise

@en

P2093

Angela R. Hess

http://www.w3.org/2001/XMLSchema#string

Dawn A. Kirschmann

http://www.w3.org/2001/XMLSchema#string

Elisabeth A. Seftor

http://www.w3.org/2001/XMLSchema#string

Katharine M. Hardy

http://www.w3.org/2001/XMLSchema#string

Mary J.C. Hendrix

http://www.w3.org/2001/XMLSchema#string

Naira V. Margaryan

http://www.w3.org/2001/XMLSchema#string

Richard E.B. Seftor

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype

VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth

Modes of resistance to anti-angiogenic therapy

Nodal expression and detection in cancer: experience and challenges

The magic of the hypoxia-signaling cascade

Notch signaling regulates left-right asymmetry determination by inducing Nodal expression

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

Molecular classification of cutaneous malignant melanoma by gene expression profiling

Tumor cell plasticity and angiogenesis in human melanomas

Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name?

P304

1115-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1031106

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.AJPATH.2012.07.013

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230790222

http://www.w3.org/2001/XMLSchema#string

P698

22944600

http://www.w3.org/2001/XMLSchema#string

P932

4851740

http://www.w3.org/2001/XMLSchema#string